Advisers to the Food and Drug Administration (FDA) on June 14 recommended the agency grant emergency authorization to Moderna’s COVID-19 vaccine for children aged 6 to 17. The advisory panel was asked whether they believe the benefits of the vaccine outweigh the risks, and unanimously voted yes following an eight-hour virtual meeting. The FDA is…
More Post-Vaccination Heart Inflammation Among Young Males After COVID Booster: CDC
June 14, 2022
admin
AMERICABrightCCP VirusCovid NewshealthHealth Newsheart inflammationPUBLIC HEALTH INFORMATIONUSUS NewsVaccines & Safety
0 Comment
Young males suffered heart inflammation at higher rates following a booster dose of Pfizer’s COVID-19 vaccine, according to newly released data from the Centers for Disease Control and Prevention (CDC). Males aged 16 or 17 had about 139 cases of myocarditis, a form of heart inflammation, per million second doses administered, according to the data, which was…
FDA: Pfizer COVID Vaccine Good for Young Children Despite More Severe Cases Among Vaccinated
U.S. Food and Drug Administration (FDA) scientists on June 13 said Pfizer’s COVID-19 vaccine performed well in young children, despite more vaccinated participants in Pfizer’s clinical trial experiencing severe illness than unvaccinated ones. The data from the trial shows it is effective “in preventing COVID-19 in the age group of 6 months through 4 years,”…
Moderna’s COVID-19 Vaccine Effective in Toddlers, Babies: FDA
Moderna’s COVID-19 vaccine is effective for children as young as 6 months old, Food and Drug Administration (FDA) scientists said in a new analysis published late June 11. “Available data support the effectiveness of the Moderna COVID-19 Vaccine in preventing symptomatic COVID-19 in pediatric age groups from 6 months through 17 years of age,” the…
FDA Decision on Novavax COVID-19 Shot May Be Delayed To Evaluate Changes in Manufacturing
The Food and Drug Administration’s (FDA) decision to authorize the Novavax COVID-19 vaccine for emergency use may be delayed due to the FDA reviewing changes to the company’s manufacturing process. Novavax told The Epoch Times that the company updated the FDA on changes to its manufacturing process on June 3, days before the advisory committee…
FDA Decision on Novavax COVID-19 Shot May Be Delayed
The Food and Drug Administration’s (FDA) decision to authorize the Novavax COVID-19 vaccine for emergency use may be delayed due to the FDA reviewing changes to the company’s manufacturing process. Novavax told The Epoch Times that the company updated the FDA on changes to its manufacturing process on June 3, days before the advisory committee…
Federal Judge Says No to Anonymity for Health Care Workers Suing Over COVID Vaccine
June 8, 2022
admin
AMERICABrightCCP VirusCovid NewshealthHealth NewsJudiciarylawsuitMaineUSUS FeaturesUS NewsVaccineVaccines & Safety
0 Comment
A federal judge ruled late last month that a group of Maine health care workers who have a lawsuit challenging the state’s COVID-19 vaccine mandate pending before the U.S. Supreme Court cannot remain anonymous. In a May 31 ruling, Maine Chief U.S. District Judge Jon Levy gave the nine workers in Maine, mostly nurses, until…
EXCLUSIVE: Congress Presses FDA on Why COVID-19 Vaccines Would be Authorized for Young Children
A group of members of Congress is pressing the U.S. Food and Drug Administration (FDA) for answers before the regulator decides whether to authorize COVID-19 vaccines for young children. All Americans aged 5 and older can get a COVID-19 vaccine. The FDA is scheduled to meet with its advisory panel on June 15 to discuss…
Food Allergies Associated With Reduced COVID-19 Infection
June 2, 2022
admin
AMERICAAnthony FauciBrightCCP VirusCovid NewsCOVID-19Food allergieshealthHealth NewsPUBLIC HEALTH INFORMATIONScienceScience NewsUSUS News
0 Comment
A study funded by the National Institutes of Health has found that people with food allergies have reduced risk of COVID-19 infection, being asthmatic conferred no extra risk of infection; but being overweight, obese, or having a high body mass index (BMI) increased the risk of infection. “The observed association between food allergy and the…
Pfizer COVID-19 Pill Does Not Provide Significant Benefit in Patients Under 65: Study
June 2, 2022
admin
BrightCCP VirusCovid NewshealthHealth NewsMiddle EastPaxlovidPfizerPUBLIC HEALTH INFORMATIONUSUS NewsWorld
0 Comment
Pfizer’s COVID-19 pill helps reduce COVID-19 hospitalizations and deaths in the elderly but provides no strong benefit for those under 65, according to a new study. Researchers in Israel gleaned data from Clalit Health Services, a health care organization that covers over half of the entire population in the country. They analyzed data from the…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta